Cerebral 5-HT release correlates with [11C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Cerebral Blood Flow and Metabolism

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1177/0271678X16629483PMID 26825776PMCID PMC5381441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• (11)C-labeling and preliminary evaluation of pimavanserin as a 5-HT2A receptor PET-radioligand.

  2015cited by this paper
• Application of cross-species PET imaging to assess neurotransmitter release in brain

  2015cited by this paper
• Serotonin 2A Receptor Agonist Binding in the Human Brain with [11C]Cimbi-36

  2014cited by this paper
• Radiosynthesis and In Vivo Evaluation of Novel Radioligands for PET Imaging of Cerebral 5-HT7 Receptors

  2014cited by this paper
• Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain.

  2013cited by this paper
• Imaging dopamine transmission in the frontal cortex: a simultaneous microdiaysis and [11C]FLB 457 PET study

  2013cited by this paper
• Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study

  2012cited by this paper
• Confirmation of Fenfluramine Effect on 5-HT1B Receptor Binding of [11C]AZ10419369 using an Equilibrium Approach

  2012cited by this paper
• Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography

  2012cited by this paper
• No change in [11C]CUMI‐101 binding to 5‐HT1A receptors after intravenous citalopram in human

  2012cited by this paper
• Sleep deprivation increases cerebral serotonin 2A receptor binding in humans.

  2012cited by this paper
• An approach for serotonin depletion in pigs: Effects on serotonin receptor binding

  2011influential reference
• Pilot study on receptor binding and serotonin sensitivity of [11C]CIMBI-36 in monkey brain

  2011cited by this paper
• Handbook of the behavioral neurobiology of serotonin

  2010cited by this paper
• Measuring Endogenous 5-HT Release by Emission Tomography: Promises and Pitfalls

  2010cited by this paper
• Measuring Drug Occupancy in the Absence of a Reference Region: The Lassen Plot Re-Visited

  2010cited by this paper
• Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder

  2009cited by this paper
• A restricted access material for rapid analysis of [(11)C]-labeled radiopharmaceuticals and their metabolites in plasma.

  2009cited by this paper
• A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation

  2009cited by this paper
• Evaluation of the Novel 5-HT4 Receptor PET Ligand [11C]SB207145 in the Göttingen Minipig

  2009cited by this paper
• First Human Evidence of d-Amphetamine Induced Displacement of a D2/3 Agonist Radioligand: A [11C]-(+)-PHNO Positron Emission Tomography Study

  2008cited by this paper
• Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

  2008cited by this paper
• Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype.

  2008cited by this paper
• Strain differences in basal and post‐citalopram extracellular 5‐HT in the mouse medial prefrontal cortex and dorsal hippocampus: relation with tryptophan hydroxylase‐2 activity

  2007cited by this paper
• Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans

  2007cited by this paper
• Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.

  2007cited by this paper
• Effect of fenfluramine‐induced increases in serotonin release on [18F]MPPF binding: A continuous infusion PET study in conscious monkeys

  2006cited by this paper
• Central serotonin depletion affects rat brain areas differently: a qualitative and quantitative comparison between different treatment schemes.

  2006cited by this paper
• Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum.

  2005cited by this paper
• Effect of Increased Serotonin Levels on [18F]MPPF Binding in Rat Brain: Fenfluramine vs the Combination of Citalopram and Ketanserin

  2005cited by this paper
• What to learn from in vivo opioidergic brain imaging?

  2005cited by this paper
• In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride

  2004cited by this paper
• [18F]altanserin Binding to Human 5HT2A Receptors is Unaltered after Citalopram and Pindolol Challenge

  2004cited by this paper
• Effects of chronic paroxetine treatment on dialysate serotonin in 5‐HT1B receptor knockout mice

  2003cited by this paper
• Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.

  2003cited by this paper
• Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.

  2002cited by this paper
• MR-Based Statistical Atlas of the Göttingen Minipig Brain

  2001cited by this paper
• Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.

  2000cited by this paper
• Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review

  2000cited by this paper
• Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys.

  1999cited by this paper
• The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET

  1999cited by this paper
• Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.

  1997cited by this paper
• Microdialysis and SPECT measurements of amphetamine‐induced dopamine release in nonhuman primates

  1997cited by this paper
• p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions.

  1997cited by this paper
• Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

  1996cited by this paper
• In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat

  1996cited by this paper
• Quantitative microdialysis of serotonin and norepinephrine: pharmacological influences on in vivo extraction fraction.

  1996cited by this paper
• Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study.

  1995cited by this paper
• Interaction between a selective 5‐HT1A receptor antagonist and an SSRI in vivo: effects on 5‐HT cell firing and extracellular 5‐HT

  1995cited by this paper
• Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus.

  1994cited by this paper
• Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis.

  1994cited by this paper
• Quantitative microdialysis under transient conditions.

  1993cited by this paper
• Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study.

  1992cited by this paper
• Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

  1992cited by this paper
• Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex

  1991cited by this paper
• Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.

  1991cited by this paper
• Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.

  1990cited by this paper
• Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis.

  1989cited by this paper
• Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats.

  1989cited by this paper
• Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine.

  1988cited by this paper

• The psychoplastogen tabernanthalog induces neuroplasticity without proximate immediate early gene activation

  2025influential citation
• Localized Nonablative Neuromodulatory Irradiation of the Nucleus Accumbens Ameliorates Voluntary Excessive Alcohol Consumption in Miniature Pigs.

  2025cites this paper
• Role of Serotonin in the Neurobiology of Schizophrenia and Association With Negative Symptoms.

  2025cites this paper
• Molecular brain imaging of psychedelic action.

  2025cites this paper
• Psychedelics, entactogens and psychoplastogens for depression and related disorders.

  2025cites this paper
• Direct serotonin release in humans shapes aversive learning and inhibition

  2024cites this paper
• Direct serotonin release in humans shapes decision computations within aversive environments

  2023cites this paper
• Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge.

  2022cites this paper
• Serotonin Receptor 5-HT2A Regulates TrkB Receptor Function in Heteroreceptor Complexes

  2022cites this paper
• Concise Review: Recent advances in neuroimaging techniques to assist clinical trials on cell-based therapies in neurodegenerative diseases.

  2022cites this paper
• Radiotracers for the Central Serotoninergic System

  2022cites this paper
• An in vivo Pig Model for Testing Novel Positron Emission Tomography Radioligands Targeting Cerebral Protein Aggregates

  2022cites this paper
• An in vivo pig model for testing novel PET radioligands targeting cerebral protein aggregates

  2022cites this paper
• Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals

  2022cites this paper
• An FMRI-compatible System for Targeted Electrical Stimulation

  2021cites this paper
• [18F]F13640, a 5-HT1A Receptor Radiopharmaceutical Sensitive to Brain Serotonin Fluctuations

  2021influential citation
• Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans

  2021influential citation
• Serotonergic imaging in Parkinson's disease.

  2021cites this paper
• An fMRI-compatible system for targeted electrical stimulation.

  2021cites this paper
• Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig.

  2020cites this paper
• A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.

  2020cites this paper
• University of Groningen Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers

  2019cites this paper
• Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

  2019cites this paper
• Dark Classics in Chemical Neuroscience: NBOMes.

  2019cites this paper
• Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge

  2019cites this paper
• Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

  2019cites this paper
• Neurotransmitters and Intermittent Explosive Disorder

  2019cites this paper
• In vivo PET Imaging of [11C]CIMBI-5, a 5-HT2AR Agonist Radiotracer in Nonhuman Primates.

  2019cites this paper
• The Use of Pigs as a Translational Model for Studying Neurodegenerative Diseases

  2019cites this paper
• Quantitative Rodent Brain Receptor Imaging

  2019cites this paper
• Measuring endogenous changes in serotonergic neurotransmission with [11C]Cimbi-36 positron emission tomography in humans

  2019cites this paper
• Automatic delineation of brain regions on MRI and PET images from the pig.

  2018cites this paper
• Cerebral serotonin release correlates with [11C]AZ10419369 PET measures of 5-HT1B receptor binding in the pig brain

  2018cites this paper
• PET Imaging of the 5-HT 2A Receptor System: A Tool to Study the Receptor’s In Vivo Brain Function

  2018cites this paper
• Hunting for the high‐affinity state of G‐protein‐coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging

  2018cites this paper
• Men with high serotonin 1B receptor binding respond to provocations with heightened amygdala reactivity

  2018cites this paper
• Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate Brain

  2017cites this paper
• In vivo evaluation of [18F]FECIMBI-36, an agonist 5-HT2A/2C receptor PET radioligand in nonhuman primate.

  2017cites this paper
• News and views on in-vivo imaging of neurotransmission using PET and MRI.

  2017cites this paper
• Serotonin and brain function: a tale of two receptors

  2017influential citation